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Abstract
Background: There is growing evidence supporting a role for TRPA1 receptors in the neurotransmission of
peripheral mechanical stimulation. In order to enhance understanding of TRPA1 contributions to
mechanotransmission, we examined the effects a selective TRPA1 receptor antagonist, A-967079, on spinal neuronal
activity following peripheral mechanical stimulation in uninjured, CFA-inflamed, and osteoarthritc (OA) rats.
Results: Systemic injection of A-967079 (30 μmol/kg, i.v.) decreased the responses of wide dynamic range (WDR),
and nociceptive specific (NS) neurons following noxious pinch stimulation of the ipsilateral hind paw in uninjured
and CFA-inflamed rats. Similarly, A-967079 reduced the responses of WDR neurons to high-intensity mechanical
stimulation (300 g von Frey hair) of the knee joint in both OA and OA-sham rats. WDR neuronal responses to low-
intensity mechanical stimulation (10 g von Frey hair) were also reduced by A-967079 administration to CFA-inflamed
rats, but no effect was observed in uninjured rats. Additionally, the spontaneous activity of WDR neurons was
decreased after A-967079 injection in CFA-inflamed rats but was unaltered in uninjured, OA, and OA-sham animals.
Conclusions: Blockade of TRPA1 receptors disrupts transmission of high-intensity mechanical stimulation to the
spinal cord in both uninjured and injured rats indicating that TRPA1 receptors have an important role in noxious
mechanosensation in both normal and pathological conditions. TRPA1 receptors also contribute to the
transmission of low-intensity mechanical stimulation, and to the modulation of spontaneous WDR firing, but only
after an inflammatory injury.
Background
The transient receptor potential (TRP)A1 receptor is
part of a larger family of TRP ion channels that includes
TRPV, TRPM, TRPC, TRPN, TRPP, and TRPML [1-3].
TRPA1 is expressed in small and medium-sized pepti-
dergic primary afferent sensory neurons that also
express TRPV1 [4-8]. A recent report has also demon-
strated localization of TRPA1 to a subclass of large dia-
meter primary afferent sensory neurons and epidermal
kerantinocytes [8]. TRPA1 is activated by a variety of
chemical irritants that include allyl isothiocyanate (mus-
tard oil), allicin, gingerol, cinnamaldehyde, eugenol, and
methysalicylate [5,6,9,10]. Local application of these
TRPA1 agonists induces spontaneous pain in humans
[11], as well as nocifensive behaviors and hypersensitiv-
ity to peripheral stimulation in animals [10,12].
There is now growing evidence demonstrating an
important role for TRPA1 receptors in mechanotrans-
mission [13-15]. TRPA1 ablated mice (TRPA1-/-) were
less sensitive to low-intensity mechanical stimuli com-
pared to wild-type mice, and responses to high-intensity
mechanical stimulation were appreciably impaired [13].
Using the skin-nerve preparation, it was found that
TRPA1 receptors in normal skin are necessary for
mechanotransmission in several type of primary afferent
fibers including slowly adapting C-fibers (all ranges of
intensity), Aδ-fiber mechanonociceptors (only high-
intensity), and slowly adapting Ab-fibers (all ranges of
intensity) [8]. Additionally, application of the TRPA1
antagonist, HC-030031 attenuated C-fiber responses to
high-intensity mechanical stimulation of normal skin
[16]. After an inflammatory injury, there is an increase
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in TRPA1 expression as well as a decrease in mechani-
cal thresholds of TRPA1-containing primary afferent
neurons [17,18]. Furthermore, mechanical sensitivity of
inflamed animals was significantly decreased by systemic
(HC-030031) or intraplantar (AP18) administration of
TRPA1 receptor antagonists [19,20].
In order to further delineate the role of TRPA1 recep-
tors in normal and pathological mechanotransmission,
we administered a selective TRPA1 receptor antagonist,
A-967079 (Figure 1), to examine its effects on spinal
nociceptive neurons in uninjured, inflamed, and osteoar-
thritic (OA) rats. Systemic delivery of A-967079 has
been shown to decrease mechanical sensitivity in several
rat models of pathological nociception [21]. We also
examined the actions of A-967079 on the spontaneous
firing of spinal wide dynamic range (WDR) neurons in
each of the animal models examined. Spontaneous activ-
ity of WDR neurons is heightened following a chronic
injury and is an indication of central sensitization and
possibly non-evoked or ongoing pain [22-27].
Methods
All animal handling and experimental protocols were
approved by Abbott’s Institutional Animal Care and Use
Committee (IACUC), and were conducted in accordance
with the ethical principles for pain-related animal
research of the American Pain Society. Male Sprague-
Dawley rats (Charles River, MA, 250-400 g) were used
for all experiments and were housed in a temperature
controlled room with a 12/12-hr day/night cycle. Food
and water were available ad libitum.
Compound
A-967079 was synthesized at Abbott Laboratories
(Abbott Park, IL). A-967079 is a TRPA1 receptor
antagonist with IC50’s of 67 nM and 289 nM at human
and rat TRPA1 receptors, respectively, and has good
penetration into the CNS [21]. A-967079 (10 μM) is
weak (ED50 > 5 μM) or not active at 89 different G-pro-
tein-coupled receptors, enzymes, transporters, and ion
channels including other TRP channels (CEREP, Poi-
tiers, France; and unpublished data), and thus is selec-
tive for TRPA1 receptors.
Animal models
Uninjured, inflamed, osteoarthritic and sham osteoar-
thritic animals were used for the experiments. Osteoar-
thritis was induced 21 days prior to electrophysiological
testing by injecting 3 mg Monoiodoacetate (MIA, 50 μl)
i.a. through the infrapatella ligament of the right knee.
Animals were anesthetized with 5% isoflurane followed
by 2.5% maintenance during the MIA injection proce-
dure. MIA was dissolved in 0.9% sterile saline and admi-
nistered using a 29-gauge needle. Sham OA animals
received an i.a injection of saline 21 days prior to test-
ing. Chronic inflammation was induced by injecting
complete Freund’s adjuvant (CFA, 50%, 150 μl) into the
plantar surface of the rat’s right hindpaw 48 hours prior
to the electrophysiology experiments.
Electrophysiological protocol
On the day of neuronal recording, all animals were initi-
ally anesthetized with pentobarbital (50 mg/kg, i.p.).
Catheters were placed into the left and right external
jugular veins. A laminectomy was performed to remove
vertebral segments T12-L3 for uninjured and CFA rats,
and T9-L2 for OA and OA-sham rats to record from
spinal neurons that receive input from either the right
paw or knee, respectively. All animals were then secured
in a stereotaxic apparatus (Kopf Instruments, Tujunga,
CA) supported by clamps attached to the vertebral pro-
cesses on either side of the exposure site. The exposed
area of the spinal cord was first enveloped by agar and
then filled with mineral oil. A stable plane of anesthesia
was maintained throughout the experiment by a contin-
uous infusion of propofol at a rate of 8-12 mg/kg/hr
(i.v.). Body temperature was kept at approximately 37°C
by placing the animals on a circulating water blanket.
Platinum-iridium microelectrodes (Frederick Haer,
Brunswick, ME) were used to record extracellular activity
of spinal dorsal horn neurons. The activity of WDR neu-
rons was recorded from all groups of rats. WDR neurons
were defined as those neurons that respond in a graded
manner to both low- and high-intensity stimulation. The
firing of nociceptive specific (NS) neurons was also
recorded from CFA and uninjured rats. NS neurons were
defined as those neurons that respond only to high-inten-
sity (noxious) stimulation. Spike waveforms were moni-
tored on an oscilloscope throughout the experiment,
digitized (32 points), and then stored for off-line analysis
(SciWorks, Datawave Technologies, Longmont, CO) to
ensure that the unit under study was unambiguously dis-
criminated throughout the experiment.
Each neuron was characterized to confirm WDR or
NS response patterns. For CFA and uninjured animals,
the neuronal receptive field (RF) on the ipsilateral hind
paw was (in order) gently tapped, brushed, given a nox-
ious pinch with forceps, and stimulated with a 10-g von
Figure 1 Structure of A-967079.
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Frey hair for 2-3 sec. In OA and OA-sham rats, neurons
were characterized by responses to manual gentle rub-
bing, and a 300-g von Frey applied to the knee for 2-3
sec. Only neurons that specifically responded to knee
joint stimulation, without responding to stimulation of
the surrounding skin/tissue, were kept for recordings in
OA and OA-sham rats.
After characterization, three baseline responses, sepa-
rated by 5 min each, to specific stimulation (see below)
of the neuronal RF were recorded. Spontaneous and
evoked neuronal activity was then measured 5, 15, 25,
and 35 min after systemic injection of A-967079 (30
μmol/kg, i.v.) or vehicle (polyethylene glycol). The intra-
venous injection of A-967079 or vehicle was completed
over a 6-7 min period. The i.v. dose of A-967079 was
selected based on extrapolated plasma levels that were
effective in behavioral studies (data not shown). Except
for 2 experiments in which two easily distinguished neu-
rons were simultaneously recorded on one electrode,
only one neuron was studied per rat. Since only one
vehicle was used in these experiments, vehicle data was
combined when a clear “no effect’ was observed in at
least 2-3 animals from a particular subset of groups (e.g.
OA and sham OA).
Only one form of test stimulation was given in each
specific experiment. In uninjured and CFA-inflamed
rats, WDR responses to either low-intensity (10 g von
Frey hair for 15 s) or high-intensity (noxious pinch with
22 mm mini bulldog clamp for 10 s) mechanical stimu-
lation of the RF on the right hindpaw were recorded.
Responses of NS neurons to noxious pinch (22 mm
mini bulldog clamp for 10 s) of the RF were also
recorded in uninjured and CFA-inflamed rats. Finally, in
OA and OA-sham rats, a 300 g von Frey hair test stimu-
lus was applied to the right knee joint for 10 s to evoke
WDR activity.
Data analysis
At the onset of each experiment, spontaneous neuronal
firing was counted for 5 min to determine baseline
levels (prior to characterization). Post-drug spontaneous
firing was measured in the 5 min leading up to each sti-
mulus at 5, 15, 25 and 35 min after injection. Evoked
activity was measured by counting the spikes during the
time of stimulus presentation. Thus, the total number of
spikes was counted for 10 s during pinch and 300 g von
Frey stimulation, and for 15 s during the 10 g von Frey
stimulation. A mean of the three pre-drug evoked sti-
muli was calculated to represent baseline evoked activ-
ity. For each neuron, the post-drug spontaneous and
evoked activity was calculated as a percent of the
respective baseline levels.
Statistical analysis was performed on baseline levels of
neuronal spontaneous activity for uninjured, CFA, OA
and OA-sham rats by conducting a one-way ANOVA
followed by a Fisher’s LSD. Baseline levels of evoked fir-
ing for a particular stimulus were compared by using
t-tests. For comparisons to baseline firing levels, statisti-
cal significance of post-drug activity was established by
using a repeated-measures ANOVA followed by a Fish-
er’s least significant difference (LSD) test. A two-way
ANOVA followed by a Fisher’s LSD was used for com-
parison of drug and vehicle groups. Post-hoc tests were
only performed if the relevant parameter was significant
in the ANOVA. All data are presented as mean ± SEM,
and a difference was considered significant if it reached
a p-value of less than 0.05.
Results
Baseline neuronal activity
Discharge activity was recorded from 63 WDR and 17
NS neurons from the deep dorsal horn with a mean
depth of 704.7 ± 23.8 μm, and 814.7 ± 45.9 μm, respec-
tively, from the surface of the spinal cord. Rates of
spontaneous and evoked firing for WDR neurons under
baseline (pre-drug) conditions in uninjured, CFA-in-
flamed, OA and OA-sham rats are shown in Table 1.
NS neuronal activity was also examined in uninjured
and CFA-inflamed rats. The mean rate of spontaneous
firing for NS neurons in uninjured and CFA-inflamed
rats was 0.03 ± 0.02 and 0.18 ± 0.06 spikes/sec, respec-
tively. However, no spontaneous firing was observed in
6 of 9 NS neurons recorded from uninjured rats and in
1 of 8 neurons recorded from CFA-inflamed rats. Thus,
due to the very low levels of spontaneous firing of NS
neurons, this measure was not used for subsequent ana-
lysis. The mean number of baseline discharges from NS
neurons following noxious pinch stimulation in unin-
jured and CFA rats was, 15.64 ± 5.02 and 16.42 ± 2.58
spikes/sec, respectively.
Table 1 Baseline discharge rates of WDR neurons
Spontaneous (spikes/sec) 10-g von Frey (spikes/sec) Noxious pinch (spikes/sec) 300-g von Frey (spikes/sec)
Uninjured 1.73 ± 0.38 10.87 ± 4.37 52.80 ± 11.34
CFA-inflamed 4.43 ± 0.79++ 19.99 ± 3.66* 44.19 ± 9.87
OA 3.93 ± 0.54+ 27.39 ± 3.83
OA-sham 2.11 ± 0.81 18.04 ± 2.45
significant vs. uninjured group +p < 0.05, and ++p < 0.01 (Fisher’s LSD), *p < 0.05 (t-test).
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Effects of A-967079 on WDR and NS neuronal activity in
uninjured and CFA-inflamed rats
Systemic administration of A-967079 (30 μmol/kg, i.v.)
reduced the responses of WDR neurons to high-inten-
sity (pinch), but not low-intensity (10 g von Frey hair)
stimulation of the RF in uninjured rats (Figure 2A, C,
D). The reduction in WDR responses to pinch was sig-
nificant compared to both baseline levels (p = 0.02,
repeated-measures ANOVA), and the vehicle group (p =
0.0002, two way ANOVA). A-967079 decreased the
evoked pinch responses of WDR neurons by approxi-
mately 30% from baseline levels. This effect was
observed 15 min after injection and remained at this
level for the duration of recording period (35 min post-
injection). Spontaneous firing of WDR neurons was not
altered by the injection of A-967079 to uninjured rats
(Figure 2B).
Similar to its actions in uninjured rats, administration
of A-967079 (30 μmol/kg, i.v.) to CFA-inflamed rats sig-
nificantly reduced WDR neuronal responses to noxious
Figure 2 In uninjured rats, (A) systemic administration of A-967079 (30 μmol/kg, i.v.) reduced WDR responses to noxious pinch (28
mm mini bulldog clamp for 10 sec), but not to 10-g von Frey stimulation (n = 5-7 per group) of the RF on the hind paw. (B)
Spontaneous firing of WDR neurons was unaltered by A-967079 injection to uninjured rats (n = 7-12 per group). Representative ratemeters
showing the responses of a single WDR neuron to; (C) 10-g von Frey hair stimulation (15 sec), and (D) a noxious pinch (28 mm mini bulldog
clamp for 10 sec) both before and after injection of A-967079 (30 μmol/kg, i.v.) to uninjured rats. VF = 10-g von Frey hair stimulation, P =
noxious pinch (mini bulldog clamp). Since vehicle did not alter WDR firing in animals receiving either a von Frey (n = 5) or pinch stimulus (n =
2), this data was combined for comparison. *p < 0.05, vs. baseline firing; +p < 0.05 vs. vehicle-treated group (Fisher’s LSD).
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pinch stimulation (Figures 3A and 4A) compared to
baseline firing (p = 0.0013, repeated-measures ANOVA)
and the vehicle group (p = 0.0001, two-way ANOVA).
The maximum observed effect (61.1 ± 10.97% decrease
from baseline levels) on pinch-evoked activity in
inflamed rats occurred 35 min after injection. In con-
trast to uninjured rats, injection of A-967079 to CFA-in-
flamed rats also significantly (p = 0.0004, and p = 0.0001
for the repeated-measures and two-way ANOVA’s,
respectively) reduced responses of WDR neurons to 10-
g von Frey hair stimulation (Figures 3A and 4B). The
maximal observed decrease in von Frey-evoked activity
was 67.69 ± 18.39% from baseline levels (35 min post-
injection), and was thus comparable to the effects of
A-967079 on pinch-evoked activity in inflamed rats.
Also in contrast to the effects in uninjured rats, sys-
temic injection of A-967079 significantly attenuated the
spontaneous firing of WDR neurons in CFA-inflamed
rats (Figures 3B and 4A, B) compared to both baseline
levels (p = 0.001, repeated-measures ANOVA) and the
vehicle group (p = 0.04, two-way ANOVA). This effect
of A-967079 on spontaneous firing was detected by 25
min after injection, and reached a maximally observed
reduction (59.27 ± 13.65% from baseline levels) 35 min
post-injection.
NS neuronal activity in both uninjured and CFA-
inflamed rats was substantially decreased by A-967079
(30 μmol/kg, i.v.) (Figure 5) compared to baseline levels
(p = 0.0001 for both groups, repeated-measures
ANOVA) as well as the vehicle group (p = 0.0004 and
p = 0.0001, two-way ANOVA for uninjured and CFA
rats, respectively). The pinch-evoked firing of NS neu-
rons was significantly (p < 0.05, Fisher’s LSD) reduced
5 min after injection of A-967079, and was nearly elimi-
nated by 25 min post-injection in both groups of rats.
Responses of NS neurons to noxious pinch stimulation
were maximally decreased by 82.09 ± 17.55%, and 92.49
± 3.79% from baseline levels in uninjured and inflamed
rats, respectively.
Effects of A-967079 on WDR neuronal activity in OA and
sham OA rats
The firing of WDR neurons was also examined in
MIA-induced OA and sham OA rats. The testing para-
meters in these two groups of rats were limited to
high-intensity stimulation due to the difficulty and ques-
tionable reliability of stimulating the knee joint through
its surrounding tissue with a low-intensity stimulus.
Responses of WDR neurons to a 300-g von Frey were
significantly reduced from baseline levels of firing
(p = 0.015 and p = 0.0009, repeated measure ANOVA,
respectively) after injection of A-967079 (30 μmol/kg, i.
v.) to both OA and sham OA rats (Figures 6A and 7).
This evoked response was also significantly reduced
Figure 3 In CFA-inflamed rats, systemic administration of A-967079 (30 μmol/kg, i.v.) reduced (A) WDR responses to noxious pinch
(28 mm mini bulldog clamp for 10 sec), and 10-g von Frey stimulation (n = 6 per group) of the RF on the hind paw. (B) Injection of
A-967079 (30 μmol/kg, i.v.) also decreased the spontaneous firing of WDR neurons in CFA-inflamed rats (n = 6-12 per group). Since vehicle
did not alter WDR firing in animals that received either a von Frey (n = 4) or pinch stimulus (n = 2), this data was combined for comparison.
*p < 0.05, **p < 0.01 vs. baseline firing; ++p < 0.01 vs. vehicle-treated group (Fisher’s LSD).
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compared to the vehicle group (p = 0.0001 for both
groups, two-way ANOVA). The effects of A-967079 in
these models were similar, as evoked firing of WDR
neurons from OA rats was maximally reduced by 42.92
± 12.3% from baseline levels, while the same stimulation
was maximally decreased by 47.35 ± 8.06% in OA-sham
rats at 35 min post-injection. Spontaneous firing of
WDR neurons was not altered by A-967079 in either
OA or OA-sham rats (Figures 6B and 7).
Discussion
Systemic administration of the selective TRPA1 receptor
antagonist, A-967079, reduced the responses of spinal
WDR and NS neurons to high-intensity mechanical sti-
mulus in both uninjured rats and in rats with OA or an
inflammatory injury. These in vivo effects add to the
growing evidence confirming that TRPA1 receptors have
an important role in the transmission of noxious
mechanical signals to the spinal cord under both normal
and pathological conditions [8,13,16,19,20]. In contrast,
the transmission of low-intensity mechanical stimulation
was impeded by A-967079 only following an inflamma-
tory injury, and was not altered in uninjured animals.
Clearly, the contributions of TRPA1 to mechanosensa-
tion shift to include lower intensity stimulation following
the inflammatory insult, and this data appears to be con-
sistent with other reports demonstrating an enhanced
role for TRPA1 during inflammation [17-20,28].
The neuronal responses to high-intensity peripheral sti-
mulation were attenuated by injection of A-967079 in
each of the animal models examined (uninjured, CFA-
inflamed, OA, and OA-sham). The intensity of the two
Figure 4 Effects of A-967079 (30 μmol/kg, i.v.) on single WDR neurons recorded from CFA-inflamed rats. Both evoked and spontaneous
firing was attenuated by injection of A-967079. VF = 10-g von Frey hair stimulation, char = characterization period, T = non-noxious tap,
B = non-noxious brush, P = noxious pinch (mini bulldog clamp). The neuronal RF on the hind paw was stimulated.
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stimuli, a clamp-inflicted pinch and 300-g von Frey hair,
would certainly be considered in the noxious range. It is
likely that A-967079 acted on a similar set of pathways
into the spinal cord to modulate the high-intensity stimu-
lation across the different animal models. Furthermore,
since both NS and WDR neuronal activity was modulated
by A-967079, these pathways likely influence both of these
classes of nociceptive neurons. Since A-967079 was admi-
nistered systemically we cannot determine its exact site(s)
of action, but expression of TRPA1 has been localized to
different sized primary afferent sensory neurons as well as
epidermal kerantinocytes [4-8]. In studies using the skin-
nerve preparation, it was reported that application of a
TRPA1 antagonist (HC-030031) did not alter the
responses of C- and A-fibers to low-intensity mechanical
stimulation of normal skin [16]. However, HC-030031
reduced the responsiveness of C-fibers once the stimulus
force was increased into the high-intensity range, but
Aδ-fiber activity was still unaffected. Thus, TRPA1 recep-
tors on C nociceptors, particularly the slow-adapting
Figure 5 (A) Systemic administration of A-967079 (30 μmol/kg, i.v.) reduced NS responses to a noxious pinch (28 mm mini bulldog
clamp for 10 sec) in both uninjured and CFA-inflamed rats (n = 5-6 per group). (B) Representative ratemeters showing the responses of a
single NS neuron to noxious pinch (10 sec) stimulation of the hind paw in uninjured (left), and CFA-inflamed (right) rats before and after
injection of A-967079 (30 μmol/kg, i.v.). P = 10 sec pinch (mini bulldog clamp) stimulation. Since vehicle did not alter NS firing in CFA (n = 3) or
uninjured animals (n = 2), this data was combined for comparison **p < 0.01 vs. baseline firing; +p < 0.05, ++p < 0.01 vs. vehicle-treated group
(Fisher’s LSD).
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subtype [13], appear to play a significant role in high-
intensity mechanotransmission. Input to the spinal cord
from these TRPA1-containing C-fibers was likely impeded
by A-967079 administration in each of the animal models
examined, and highlights the importance of this subclass
of afferent neurons in transferring noxious mechanical sti-
mulation from the periphery to the spinal cord in both
normal and pathological states. It is interesting to note
that while WDR neuronal responses to high-intensity sti-
muli were significantly attenuated by injection of A-
967079, the responses of NS neurons to the same simula-
tion were almost completely eliminated. WDR neuronal
activity is influenced by a diversity of afferent fibre types,
including non-TRPA1-containing fibers. Thus, it is not
surprising that the responses of WDR neurons to high-
intensity mechanical stimulation were not totally blocked
by the injection of A-967079. When combined with the
localization data, the almost complete suppression of NS
neuronal firing after administration of A-967079 suggests
that the mechanical responses of this neuronal class are
greatly influenced by input from a specific set of C-fibers
that contain TRPA1 receptors.
The transmission of low-intensity mechanical stimula-
tion to WDR neurons was also reduced by A-967079
administration, but only in the CFA-inflamed rats. This
additional action of A-967079 in CFA-injected rats indi-
cates that TRPA1 has a role in mechanical hypersensi-
tivity during inflammation. Consistent with this data,
injection of TRPA1 receptor antagonists, HC-030031
and AP18, reduced behavioral mechanical hypersensitiv-
ity in CFA-inflamed animals [19,20]. The mechanical
thresholds of TRPA1-containing primary afferent neu-
rons have been shown to shift lower following CFA-
induced inflammation [18], and may be the means
through which A-967079 attenuated WDR responses to
low-intensity stimulation. There are several factors that
may contribute to the lowering of mechanical thresholds
for TRPA1-containing neurons after CFA injection,
including TRPA1 upregulation in the dorsal root gang-
lion [17,18], and direct activation or indirect sensitiza-
tion of the receptor by bradykinin, prostaglandins, and
other endogenous agents released during inflammation
[8,10,28-32]. We did not examine the effects of A-
967079 on low-intensity stimulation in OA rats due to
the difficulty in reproducibly stimulating the knee joint
through surrounding skin/tissue with a low force stimu-
lus. Nonetheless, antagonism of TRPA1 receptors
reduces mechanical allodynia in neuropathic rats [19],
demonstrating that TPRPA1 receptors may have a role
in pathological mechanotransmission in a model other
than inflammatory injury.
A-967079 also reduced the “heightened” spontaneous
firing of WDR neurons in CFA-inflamed rats. As we
and others have observed previously, the spontaneous
firing of WDR neurons is elevated following CFA-
induced inflammation [23,24,33-35], and likely reflects
Figure 6 In OA and OA-sham rats, systemic administration of A-967079 (30 μmol/kg, i.v.) reduced (A) the responses of WDR neurons
high-intensity von Frey hair stimulation (300 g for 10 s) of the knee joint, but did not alter the (B) spontaneous firing of WDR
neurons (n = 7-8 per group). Since vehicle did not alter WDR firing in OA (n = 5) or OA-sham rats (n = 2), this data was combined for
comparison. *p < 0.05, **p < 0.01 vs. baseline firing; +p < 0.05, ++p < 0.01 vs. vehicle-treated group (Fisher’s LSD).
McGaraughty et al. Molecular Pain 2010, 6:14
http://www.molecularpain.com/content/6/1/14
Page 8 of 11
injury-related sensitization of this class of spinal neurons
[22-27]. Given that WDR neurons are an integral com-
ponent of the ascending nociceptive pathway, and that
higher levels of WDR firing generally code for increased
somatosensory intensity, the observation that WDR neu-
rons in inflamed rats spontaneously discharge at rates
higher than normal may indicate that there is unevoked
or “nagging” discomfort in the animal. Unevoked pain is
observed in the majority of patients with chronic pain,
and is a primary reason for seeking medical care [36,37].
Suzuki and Dickenson [27] have reported that heigh-
tened spontaneous discharges of WDR neurons are
either reduced, or unaltered by drugs that are effective
or ineffective, respectively, in treating unevoked pain in
humans. Since accurate assessment of unevoked pain in
animals is difficult [38], examining the ongoing firing of
WDR neurons in animal models of pathological pain
may provide some insight into this undesirable condi-
tion. The current data would suggest that antagonism of
TRPA1 receptors may be an effective means to alleviate
unevoked pain or discomfort following an inflammatory
injury.
Spontaneous firing of WDR neurons was also elevated
in OA rats, but unlike in CFA-inflamed rats, this
increase in ongoing discharges was not altered by injec-
tion of A-967079. One difference between these models
was the site of neuronal recording since input from the
knee (OA) and hind paw (CFA) arrive at different
Figure 7 Effects of A-967079 (30 μmol/kg, i.v.) on single WDR neurons recorded from either (A) an OA-sham or (B) an OA rat. In both
cases, A-967079 reduced the evoked responses of WDR neurons following high-intensity stimulation (300 g von Frey for 10 s), but did not
change the spontaneous activity. R = gentle manual rubbing of the knee joint, VF = 300-g von Frey hair stimulation of the knee, char =
characterization period.
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sections of the lumbar spinal cord. However, both of
these sections are likely influenced by fibers containing
TRPA1 receptors since injection of A-967079 decreased
evoked neuronal firing in both OA and CFA rats. Albeit
speculative, the differential effect of A-967079 on spon-
taneous firing in CFA and OA rats may be more related
to the degree of inflammation on the days of neuronal
recording. In the MIA-induced model of OA, inflamma-
tion of the knee region has mostly dissipated by day 7
after the MIA insult [39]. Thus, inflammation would not
factor into the neuronal activity recorded on day 21 in
OA rats. In contrast, the release of inflammatory media-
tors in the CFA assay may be an important component
to the augmented contributions of TRPA1 in this model
[28,30,31]. These mediators probably not only factored
into the effects of A-967079 on low-intensity mechanical
stimulation, but also on the antagonist-related reduction
of heightened spontaneous firing.
Conclusions
The TRPA1 receptor has a significant role in the trans-
mission of high-intensity mechanical stimulation to dif-
ferent classes of spinal nociceptive neurons in uninjured,
inflamed and osteoarthritic animals. Additionally, there
is an enhanced role for TRPA1 receptors following an
inflammatory injury that includes modulation of low-
intensity mechanical input to the spinal cord, and redu-
cing elevated levels of spontaneous WDR neuronal fir-
ing. Thus, blockade of TRPA1 receptors is likely to be
an effective means to alleviate pain associated with
intense mechanical stimulation in both normal and
pathological conditions, as well as reducing mechanical
allodynia and “nagging” or unevoked pain after an
inflammatory injury.
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